摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[(2R,3S)-2-[(1R,2R)-2-fluoro-1-hydroxy-2-phenylethyl]-6-oxo-2,3-dihydropyran-3-yl]acetamide

中文名称
——
中文别名
——
英文名称
N-[(2R,3S)-2-[(1R,2R)-2-fluoro-1-hydroxy-2-phenylethyl]-6-oxo-2,3-dihydropyran-3-yl]acetamide
英文别名
——
N-[(2R,3S)-2-[(1R,2R)-2-fluoro-1-hydroxy-2-phenylethyl]-6-oxo-2,3-dihydropyran-3-yl]acetamide化学式
CAS
——
化学式
C15H16FNO4
mdl
——
分子量
293.29
InChiKey
APJHZKFYSNQBFG-PMOUVXMZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    21
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    75.6
  • 氢给体数:
    2
  • 氢受体数:
    5

文献信息

  • [EN] HETEROCYCLO COMPOUNDS AS APOPTOTIC INDUCERS AND USES THEREOF<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES UTILISÉS COMME INDUCTEURS D'APOPTOSE ET LEURS UTILISATIONS
    申请人:KUNMING INST BOTANY CN ACAD
    公开号:WO2014117741A1
    公开(公告)日:2014-08-07
    Disclosed are heterocyclo compounds that have a formula represented by the following: and wherein X, R1, R2, R3, R4, R5, R6, and n are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of cancer conditions in mammals including humans, including by way of non-limiting example, prostate, colon, bladder, melanoma, liver, breast, cervical, ovarian, esophagi, glialblastoma, pancreatic and lung cancer.
    本公开揭示了具有以下表示的化学式的杂环化合物:其中X,R1,R2,R3,R4,R5,R6和n如本文所述。这些化合物可以制备为药物组合物,并可用于预防和治疗包括人类在内的哺乳动物的多种癌症病况,例如前列腺癌、结肠癌、膀胱癌、黑色素瘤、肝癌、乳腺癌、宫颈癌、卵巢癌、食管癌、神经胶质母细胞瘤、胰腺癌和肺癌等。
  • HETEROCYCLO COMPOUNDS AS APOPTOTIC INDUCERS AND USES THEREOF
    申请人:KUNMING INSTITUTE OF BOTANY, CHINESE ACADEMYOF SCIENCES
    公开号:US20150361062A1
    公开(公告)日:2015-12-17
    Disclosed are heterocyclo compounds that have a formula represented by the following: and wherein X, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and n are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of cancer conditions in mammals including humans, including by way of non-limiting example, prostate, colon, bladder, melanoma, liver, breast, cervical, ovarian, esophagi, glialblastoma, pancreatic and lung cancer.
  • US9682947B2
    申请人:——
    公开号:US9682947B2
    公开(公告)日:2017-06-20
查看更多